Aller au contenu principal
Profil bibliographique

Jeffrey M. Verboon

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

51Publications signalées
2289Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cellular Mechanics and InteractionsCellular transport and secretionRNA modifications and cancerEpigenetics and DNA MethylationRNA Research and Splicing

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

Spatiotemporal Dynamics of Protein Recruitment During Cell Wound Repair

Mitsutoshi Nakamura, Justin Hui, Jeffrey M. Verboon, Susan M. Parkhurst

Abstract Injuries to individual cells happen frequently as a result of physiological and environmental stresses during their normal daily functions that can lead to a ruptured cell cortex (plasma membrane and underlying cortical cytoskeleton). The capacity of cells to rapidly repair general …

us (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
2025 conference-abstract OpenAlex

Abstract 2126: LY6G6D targeting with a T cell engager is a promising therapeutic for MSS colorectal cancer

Burcu Yigit, Prasuna Paluru, Eglė Jurgaitytė, Kevin A. Nuno et autres

T cell engagers (TCEs) are proving to be a potent therapeutic strategy for the treatment of solid tumors. Clinical data have shown that TCEs can drive T cell activity in "cold" tumors, including colorectal cancer. However, identifying highly specific tumor antigen targets …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2024 article OpenAlex

Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies

Matthew A. Nix, Caleb A. Lareau, Jeffrey M. Verboon, David Kugler

Targeted antibody-based therapy for oncology represents a highly efficacious approach that has demonstrated robust responses against single tumor-associated antigen (TAA) targets. However, tumor heterogeneity presents a major obstacle for targeting most solid tumors due to a lack of single targets that possess …

us (code pays fourni par la source)

14 citations Frontiers in Immunology
Accès ouvert 2024 conference-abstract OpenAlex

1343 A CB21-targeted T cell engager is a promising therapeutic for the treatment of colorectal cancer

Burcu Yigit, Prasuna Paluru, Eglė Jurgaitytė, Kevin A. Nuno et autres

Background Colorectal cancer (CRC) remains of high unmet medical need. T cell engagers as a modality have gained attraction in solid tumors, but despite the early data that T cells can infiltrate cold CRC tumors with therapies such as Cibisatamab, treatment remains …

0 citations Regular and Young Investigator Award Abstracts
Accès ouvert 2024 article OpenAlex

Genome Sequencing for Diagnosing Rare Diseases

Monica H. Wojcik, Gabrielle Lemire, Eva Berger, Maha S. Zaki et autres

BACKGROUND: Genetic variants that cause rare disorders may remain elusive even after expansive testing, such as exome sequencing. The diagnostic yield of genome sequencing, particularly after a negative evaluation, remains poorly defined. METHODS: We sequenced and analyzed the genomes of families with …

us (code pays fourni par la source)

203 citations New England Journal of Medicine
Accès ouvert 2023 article OpenAlex

A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology

Parsa Akbari, Dragana Vuckovic, Luca Stefanucci, Tao Jiang et autres

Blood cells contain functionally important intracellular structures, such as granules, critical to immunity and thrombosis. Quantitative variation in these structures has not been subjected previously to large-scale genetic analysis. We perform genome-wide association studies of 63 flow-cytometry derived cellular phenotypes-including cell-type specific …

gb, us, de, it, nl (code pays fourni par la source)

38 citations Nature Communications
Accès ouvert 2023 preprint OpenAlex

Unique Capabilities of Genome Sequencing for Rare Disease Diagnosis

Monica H. Wojcik, Gabrielle Lemire, Maha S. Zaki, Mariel Wissman et autres

Background: Causal variants underlying rare disorders may remain elusive even after expansive gene panels or exome sequencing (ES). Clinicians and researchers may then turn to genome sequencing (GS), though the added value of this technique and its optimal use remain poorly defined. …

us, Égypte, au, gb, ca, ee (code pays fourni par la source)

8 citations medRxiv
Accès ouvert 2023 article OpenAlex

Centralspindlin proteins Pavarotti and Tumbleweed along with WASH regulate nuclear envelope budding

Kerri Davidson, Mitsutoshi Nakamura, Jeffrey M. Verboon, Susan M. Parkhurst

Nuclear envelope (NE) budding is a nuclear pore-independent nuclear export pathway, analogous to the egress of herpesviruses, and required for protein quality control, synapse development, and mitochondrial integrity. The physical formation of NE buds is dependent on the Wiskott-Aldrich Syndrome protein, Wash, …

Afrique du Sud, us (code pays fourni par la source)

4 citations The Journal of Cell Biology
Accès ouvert 2022 preprint OpenAlex

Single-cell multi-omics reveals dynamics of purifying selection of pathogenic mitochondrial DNA across human immune cells

Caleb A. Lareau, Sonia M. Dubois, Frank A. Buquicchio, Yu-Hsin Hsieh et autres

Abstract Cells experience intrinsic and extrinsic pressures that affect their proclivity to expand and persist in vivo . In congenital disorders caused by loss-of-function mutations in mitochondrial DNA (mtDNA), metabolic vulnerabilities may result in cell-type specific phenotypes and depletion of pathogenic alleles, …

us, de (code pays fourni par la source)

4 citations bioRxiv (Cold Spring Harbor Laboratory)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.